Simultaneous determination of cyclosporine, sirolimus, and tacrolimus in whole blood using liquid chromatography-tandem mass spectrometry

Methods in Molecular Biology

Volumn 902, Issue , 2012, Pages 167-173

  Garg, Uttam ^a   Munar, Ada ^a   Frazee III, C Clinton ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Cyclosporine; Mass spectrometry; Sirolimus; Tacrolimus; Therapeutic drug monitoring

Indexed keywords

CYCLOSPORIN; RAPAMYCIN; TACROLIMUS;

ARTICLE; BLOOD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; TANDEM MASS SPECTROMETRY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOSPORINE; HUMANS; SIROLIMUS; TACROLIMUS; TANDEM MASS SPECTROMETRY;

EID: 84865333395     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-934-1_15     Document Type: Article

References (11)

1. Gupta NR, Granger DK, Matto TK, Gruber SA (2005) Immunosupressive and immunomodulatory drugs. In: Yaffe SJ, Aranda JV (eds) Neonatal and pediatric pharmacology: therapeutic principles in practice, 3rd edn. Lippincott Williams and Wilkins, Philadelphia, pp 626-637
2. Tamura K, Fujimura T, Iwasaki K, Sakuma S, Fujitsu T, Nakamura K, Shimomura K, Kuno T, Tanaka C, Kobayashi M (1994) Interaction of tacrolimus(FK506) and its metabolites with FKBP and calcineurin. Biochem Biophys Res Commun 202:437-443
3. Kelly KA (2010) Pharmacokinetics and therapeutic drug monitoring of immunosuppressants. In: Dasgupta A (ed) Advances in chromatographic techniques for therapeutic drug monitoring. CRC, Boca Raton, pp 209-238
4. Oellerich M, Armstrong VW (2002) Two-hour cyclosporine concentration determination: an appropriate tool to monitor neoral therapy? Ther Drug Monit 24:40-46
5. Cantarovich M, Elstein E, de Varennes B, Barkun JS (1999) Clinical bene fi t of neoral dose monitoring with cyclosporine 2-hr postdose levels compared with trough levels in stable heart transplant patients. Transplantation 68:1839-1842
6. Butch AW (2007) Introduction to immunosupressive drug monitoring. In: Dasgupta A (ed) Therapeutic drug monitoring data, 3rd edn. AACC, Washington, DC, pp 129-161
7. Taylor PJ (2004) Therapeutic drug monitoring of immunosuppressant drugs by high-performance liquid chromatography-mass spectrometry. Ther Drug Monit 26:215-219
8. Deters M, Kirchner G, Resch K, Kaever V (2002) Simultaneous quanti fi cation of sirolimus, everolimus, tacrolimus and cyclosporine by liquid chromatography-mass spectrometry (LC-MS). Clin Chem Lab Med 40:285-292
9. Dasgupta A (2010) Introduction to therapeutic drug monitoring and chromatography. In: Dasgupta A (ed) Advances in chromatographic techniques for therapeutic drug monitoring. CRC, Boca Raton, pp 1-38
10. Volosov A, Napoli KL, Soldin SJ (2001) Simultaneous simple and fast quanti fi cation of three major immunosuppressants by liquid chromatography-tandem mass-spectrometry. Clin Biochem 34:285-290
11. Garg U, Sandritter TL, Leeder JS (2010) Pediatric therapeutic drug monitoring, toxicology and pharmacogenetics. In: Dietzen DJ, Bennett M, Wong ECC (eds) Biochemical and molecular basis of pediatric disease, 4th edn. AACC, Washington, DC, pp 531-560